跳至主要内容
临床试验/CTRI/2024/10/075108
CTRI/2024/10/075108尚未招募2 期

Clinical evaluation of Shatavaryadi Ghrita In Paittik Mutrakrichhra

ALOK KUMAR SHARMA1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年10月24日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To help relief in symptoms of paittik mutrakrichhra

研究概览

简要总结

This Is An Open Label Clinical Study To Evaluate The Effect Of Shatavaryadi Ghrita  In The Management Of Mutrakrichhra (Urinary Tract Infections) It will be a clinical study of 30 patients suffering from urinary tract infections. patient will be randomly selected irrespective of their gender,race,religion,occupation-patient with classical features of Mutrakrichhra attending the OPD and IPD  of Kayachikitsa department of Quadra institute of Ayurveda Roorkee will be selected for this clinical study. The patients between the age group of 15 to 50 years of age.The assessment of the trial will be done on the basis of subjective and objective parameters.The period of study is 18 months and duration of study is 15 days.Data depending upon above subjective and objective criteria and other variables will be collected and analyzed statistically

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
15.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Individuals between the age group of 15-50 years will be selected.
  • Individuals irrespective of gender, religion, race, occupation will be selected for the study.
  • Individuals with classical signs and symptoms of Paittik Mutrakrichhra will be selected
  • Abnormally increased pus cell and leucocytes increases in urine sample.
  • New and previously treated cases would be taken for the study.

排除标准

  • Individuals aged group of below 15 and above 50 years will be excluded.
  • Pregnant or lactating women will be excluded.
  • Individuals with a history of renal diseases, diabetes mellitus, diabetes insipidus, pyelonephritis ,uncontrolled hypertension, surgical history (phimosis) ,severe complication of the cardiovascular or hematopoietic systems , mental diseases and any other major illness will excluded.
  • Individuals with a history of complicated urinary tract infections.

结局指标

主要结局

To help relief in symptoms of paittik mutrakrichhra

时间窗: First follow up-after 7 days of first trial | Second follow up-7 days after first follow up

次要结局

  • Provide a alternative & safe treatment for(pittaja mutrakricchra)

研究者

发起方
ALOK KUMAR SHARMA
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Alok Kumar Sharma

Quadra Institute of Ayurveda and Hospital

研究点 (1)

Loading locations...

相似试验